Medplus Health Services Limited Cash Flow Conversion Efficiency
Medplus Health Services Limited cash flow conversion efficiency. Based on the latest financial reports, Medplus Health Services Limited (MEDPLUS) has a cash flow conversion efficiency ratio of 0.170x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.13 Billion ≈ $33.89 Million USD) by net assets (Rs18.44 Billion ≈ $199.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Medplus Health Services Limited (2019–2026)
Cash flow conversion efficiency of Medplus Health Services Limited from 2019 to 2026. This chart illustrates how Medplus Health Services Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Medplus Health Services Limited for real-time trading data and today's change.
Medplus Health Services Limited Cash Flow Conversion Ratio Explained
Medplus Health Services Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Medplus Health Services Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medplus Health Services Limited ranked by their cash flow conversion efficiency. Also see MEDPLUS market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mid Penn Bancorp
NASDAQ:MPB
|
0.032x |
|
Besalco Sa
SN:BESALCO
|
0.062x |
|
Zhejiang Zhengguang Industrial Co. Ltd.
SHE:301092
|
N/A |
|
Sirio Pharma
SHE:300791
|
0.038x |
|
Dometic Group AB (publ)
ST:DOM
|
-0.002x |
|
Onechance
SHE:300792
|
0.014x |
|
Shanghai Bolex Food Technology Co. Ltd.
SHG:603170
|
N/A |
|
TTK Prestige Limited
NSE:TTKPRESTIG
|
0.018x |
Annual Cash Flow Conversion Efficiency for Medplus Health Services Limited (2019–2026)
The table below shows the annual cash flow conversion efficiency of Medplus Health Services Limited from 2019 to 2026. Review MEDPLUS free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs19.75 Billion ≈ $213.55 Million |
Rs5.27 Billion ≈ $56.99 Million |
0.267x | -16.25% |
| 2025-03-31 | Rs17.40 Billion ≈ $188.16 Million |
Rs5.54 Billion ≈ $59.96 Million |
0.319x | +249.68% |
| 2024-03-31 | Rs15.77 Billion ≈ $170.59 Million |
Rs1.44 Billion ≈ $15.54 Million |
0.091x | +50.23% |
| 2023-03-31 | Rs14.91 Billion ≈ $161.19 Million |
Rs904.10 Million ≈ $9.78 Million |
0.061x | -49.40% |
| 2022-03-31 | Rs14.17 Billion ≈ $153.27 Million |
Rs1.70 Billion ≈ $18.37 Million |
0.120x | +2931.44% |
| 2021-03-31 | Rs7.31 Billion ≈ $79.07 Million |
Rs28.91 Million ≈ $312.65K |
0.004x | +131.75% |
| 2020-03-31 | Rs5.29 Billion ≈ $57.22 Million |
Rs-65.89 Million ≈ $-712.58K |
-0.012x | -102.47% |
| 2019-03-31 | Rs2.91 Billion ≈ $31.51 Million |
Rs1.47 Billion ≈ $15.86 Million |
0.503x | -- |
About Medplus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more